Literature DB >> 20465372

The role of patient satisfaction in methadone treatment.

Sharon M Kelly1, Kevin E O'Grady, Barry S Brown, Shannon Gwin Mitchell, Robert P Schwartz.   

Abstract

BACKGROUND: Patient satisfaction surveys, widely used in health care delivery systems, may provide useful data for improving patient retention and outcomes.
OBJECTIVES: This study examined the relationship between methadone patients' treatment satisfaction at three months post-admission and their 3-month treatment outcomes and 12-month treatment retention.
METHODS: New methadone treatment admissions (N = 283) were assessed at 3 months post-admission for satisfaction with their counselors and programs. Correlations examined the relationship between 3-month satisfaction and Addiction Severity Index (ASI) scores. Regression analysis assessed the relationship between satisfaction and drug testing at 3 months and was used to predict whether participants were retained in treatment at 12 months.
RESULTS: Participants who were more satisfied with their counselors and programs had lower Drug and Legal ASI composite scores at 3 months. Participants who were more satisfied with their programs remained in treatment for at least 12 months.
CONCLUSIONS: Treatment programs should consider administering the CEF to their patients at 3 months post-admission to identify patients with low satisfaction scores who may be at risk for prematurely leaving treatment. SCIENTIFIC SIGNIFICANCE: Measuring patient satisfaction during treatment may help programs meet patients' needs and improve retention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20465372      PMCID: PMC2938880          DOI: 10.3109/00952991003736371

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  16 in total

Review 1.  Truth or consequences: the validity of self-report data in health services research on addictions.

Authors:  F K Del Boca; J A Noll
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

2.  Consumers' and providers' perspectives about consumer participation in drug treatment services: is there support to do more? What are the obstacles?

Authors:  Joanne Bryant; Melissa Saxton; Annie Madden; Nicky Bath; Suzanne Robinson
Journal:  Drug Alcohol Rev       Date:  2008-03

Review 3.  Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons.

Authors:  A T McLellan; G E Woody; D Metzger; J McKay; J Durrell; A I Alterman; C P O'Brien
Journal:  Milbank Q       Date:  1996       Impact factor: 4.911

4.  Client engagement and change during drug abuse treatment.

Authors:  D D Simpson; G W Joe; G Rowan-Szal; J Greener
Journal:  J Subst Abuse       Date:  1995

5.  Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.

Authors:  José Pérez de Los Cobos; Joan Trujols; Juan Carlos Valderrama; Sergi Valero; Teresa Puig
Journal:  Drug Alcohol Depend       Date:  2005-09-01       Impact factor: 4.492

6.  A case study using a patient satisfaction survey to improve the delivery and effectiveness of drug addiction treatment services: marketing implications and organizational impact.

Authors:  Beth Hogan; Lewis Hershey; Steven Ritchey
Journal:  Health Mark Q       Date:  2007

7.  In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; James A Peterson; Heather S Reisinger; Shannon G Mitchell; Monique E Wilson; Michael H Agar; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

8.  Patient satisfaction and sustained outcomes of drug abuse treatment.

Authors:  Dean R Gerstein; Peter D Friedmann
Journal:  J Health Psychol       Date:  2008-04

9.  Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

Authors:  Annie Madden; Toby Lea; Nicky Bath; Adam R Winstock
Journal:  Drug Alcohol Rev       Date:  2008-11

10.  Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E O'Grady; Shannon Gwin Mitchell; Heather Schacht Reisinger; James A Peterson; Michael H Agar; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

View more
  33 in total

1.  Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.

Authors:  Andjela Baewert; Reinhold Jagsch; Bernadette Winklbaur; Gerda Kaiser; Kenneth Thau; Annemarie Unger; Constantin Aschauer; Manfred Weninger; Verena Metz
Journal:  Eur Addict Res       Date:  2012-02-21       Impact factor: 3.015

2.  Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.

Authors:  Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Stephen A Metcalf; Alan J Budney; Emily Scherer; Lisa A Marsch
Journal:  J Subst Abuse Treat       Date:  2020-01-21

3.  Counseling Staff's Views of Patient-Centered Methadone Treatment: Changing Program Rules and Staff Roles.

Authors:  Shannon Gwin Mitchell; Laura B Monico; Elizabeth Lertch; Sharon M Kelly; Jan Gryczynski; Jerome H Jaffe; Kevin E O'Grady; Robert P Schwartz
Journal:  J Behav Health Serv Res       Date:  2018-07       Impact factor: 1.505

4.  Predictors of methadone treatment retention from a multi-site study: a survival analysis.

Authors:  Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2011-02-09       Impact factor: 4.492

5.  Correlation between interleukin-6 levels and methadone maintenance therapy outcomes.

Authors:  Ru-Band Lu; Tzu-Yun Wang; Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; Shih-Hsien Lin; Chun-Hsien Chu; San-Yuan Huang; Nian-Sheng Tzeng; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Ping Chen; Shih-Heng Chen; Jau-Shyong Hong
Journal:  Drug Alcohol Depend       Date:  2019-08-30       Impact factor: 4.492

6.  Factors related to client satisfaction with methadone maintenance treatment in China.

Authors:  Li Li; W Scott Comulada; Chunqing Lin; Julie Hsieh; Sitong Luo; Zunyou Wu
Journal:  J Subst Abuse Treat       Date:  2017-02-24

7.  Patient-centered methadone treatment: a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Jan Gryczynski; Kevin E O'Grady; Devang Gandhi; Yngvild Olsen; Jerome H Jaffe
Journal:  Addiction       Date:  2016-11-10       Impact factor: 6.526

8.  Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.

Authors:  M Eugenia Socias; Evan Wood; Huiru Dong; Rupinder Brar; Paxton Bach; Sean M Murphy; Nadia Fairbairn
Journal:  Contemp Clin Trials       Date:  2020-03-16       Impact factor: 2.226

9.  Effects of sex composition on group processes in alcohol prevention groups for teens.

Authors:  Tracey A Garcia; Guadalupe A Bacio; Kristin Tomlinson; Benjamin O Ladd; Kristen G Anderson
Journal:  Exp Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.157

10.  Provider-Client Interaction in Methadone Treatment Clinics in China.

Authors:  Li Li; Zunyou Wu; Xiaobin Cao; Linglin Zhang
Journal:  J Drug Issues       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.